For example, AON therapy targeted against the 3′ splice site of exon 7a of CLCN1 pre-mRNA was found to effectively eliminate chloride channelopathy in DM1 mouse models by inhibiting the inclusion of exon 7a, which restores the full-length reading frame [203]. This evidence concerns the gene CLCN1 and myotonic dystrophy type 1.